🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shirish M. Gadgeel

Henry Ford Health System

ORCID: 0000-0001-5240-3811

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium”.

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00247-3

N/A

5.0DataRank · unranked

445 citations

Giuseppe Curigliano, Dong‐Wan Kim, Ki Hyeong Lee, Benjamin Besse, Christina S. Baik +20 more

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

New England Journal of Medicine(2018)10.1056/nejmoa1801005

N/A

1.3DataRank · unranked

6524 citations

Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis +34 more

Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3947

N/A

0.862DataRank · unranked

21 citations

Jieling Miao, Jonathan W. Riess, James Moon, Philip C. Mack, Gregory J. Gerstner +10 more

SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0361

N/A

0.639DataRank · unranked

70 citations

Manish R. Sharma, Melissa L. Johnson, Timothy A. Yap, Shirish M. Gadgeel, Dale Nepert +20 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0.529DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Novel Combinations Using Pemetrexed in Malignant Mesothelioma

Clinical Lung Cancer(2004)10.3816/clc.2004.s.005

N/A

0.345DataRank · unranked

3 citations

Harvey I. Pass, Shirish M. Gadgeel

Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials

Cancer(2020)10.1002/cncr.33142

N/A

0DataRank · unranked

111 citations

Corey J. Langer, Luis Paz‐Ares, Delvys Rodríguez‐Abreu, Balázs Halmos, Marina Chiara Garassino +8 more

Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0174

N/A

0DataRank · unranked

11 citations

Christine M. Lusk, Angela S. Wenzlaff, Christine Neslund‐Dudas, Shirish M. Gadgeel, Ayman O. Soubani +2 more

Data from SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy

(2023)10.1158/2159-8290.c.6679570

N/A

0DataRank · unranked

0 citations

Manish R. Sharma, Melissa L. Johnson, Timothy A. Yap, Shirish M. Gadgeel, Dale Nepert +20 more

Polygenic risk scores in assessing lung cancer susceptibility in non-Hispanic White and Black populations.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10548

N/A

0DataRank · unranked

0 citations

Chrissy Lusk, Angie S. Wenzlaff, Christine Neslund‐Dudas, Shirish M. Gadgeel, Ayman O. Soubani +2 more

BUB1 Inhibition Overcomes Radio- and Chemoradiation Resistance in Lung Cancer

Cancers(2024)10.3390/cancers16193291

N/A

0DataRank · unranked

6 citations

Sushmitha Sriramulu, Oudai Hassan, Stephen L. Brown, Farzan Siddiqui, Benjamin Movsas +3 more

BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.19.590355

N/A

0DataRank · unranked

6 citations

Sushmitha Sriramulu, Oudai Hassan, Stephen L. Brown, Farzan Siddiqui, Benjamin Movsas +3 more

Tribbles 2 confers enzalutamide resistance in prostate cancer by promoting lineage plasticity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.26.437250

N/A

0DataRank · unranked

2 citations

Indra Adrianto, Craig Rogers, Shirish M. Gadgeel, Dhananjay Chitale, Joshi J. Alumkal +4 more